ATLASDermata Therapeutics (DRMA) earnings date: Nov 13, 2026
Dermata Therapeutics (DRMA) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 13, 2026.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on DRMA
| Last price | $0.75 (-3.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±8.3% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Dermata Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Dermata Therapeutics reports on Nov 13, 2026. One email the day before, with ATLAS’s read on Dermata Therapeutics. You can switch it off at any time.
Alert me before DRMA reportsFree to start. Creating an account takes under a minute.
Notify me when Dermata Therapeutics reports
Track DRMA free Add Dermata Therapeutics to a free ATLAS watchlist and see its next report date in one place.
DRMA earnings at a glance
| Next report (confirmed) | Fri, Nov 13, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| Last report | Aug 11, 2026 · Miss |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | +9.0% |
| Average move around a report | ±12.7% (last 4) |
| Sector | Healthcare · Biotechnology |
Dermata Therapeutics earnings history: last 4 reports
Dermata Therapeutics last reported on Aug 11, 2026: EPS of -$0.74 against an estimate of -$0.55 (-34.6% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 11, 2026 | -$0.55 | -$0.74 | -34.6% | Miss | +23.2% |
| Jun 18, 2026 | -$0.20 | -$0.08 | +60.0% | Beat | -7.5% |
| May 13, 2026 | -$0.53 | -$0.48 | +9.4% | Beat | -0.8% |
| Mar 26, 2026 | -$1.54 | -$1.52 | +1.3% | In line | -19.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for DRMA
See the fair value, the probability range and the earnings history of Dermata Therapeutics on its ATLAS page.
Dermata Therapeutics (DRMA) stock analysisPlans from €3.99 a month.
Dermata Therapeutics earnings: frequently asked questions
When does Dermata Therapeutics (DRMA) report earnings?
Dermata Therapeutics is scheduled to report on Friday, November 13, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
How often does DRMA beat earnings estimates?
Of its last 4 reports with a recorded result, Dermata Therapeutics beat the EPS estimate 2 times; the average surprise was +9.0%. Past results do not predict the next one.
How much does DRMA move around earnings?
Over its last 4 reports the stock moved an average of 12.7% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
Did Dermata Therapeutics beat earnings estimates last quarter?
Dermata Therapeutics last reported on Aug 11, 2026: EPS of -$0.74 against an estimate of -$0.55 (-34.6% surprise), a miss.
How much does DRMA usually move in a day?
On a normal trading day the ATLAS model puts DRMA’s one-day range at about ±8.3%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 13, 2026
Educational information, not investment advice. Disclaimer